Abstract:The utilization of contrast media (CM) in clinical diagnostic imaging and interventional procedures has escalated, leading to a gradual increase in the incidence of contrast-induced acute kidney injury (CI-AKI). Presently, the scarcity of effective pharmacological treatments for CI-AKI poses significant challenges to clinical management. Firstly, we explore the pathogenesis of CI-AKI in this review. Beyond renal medullary ischemia and hypoxia, oxidative stress, cellular apoptosis, and inflammation, emerging mechanisms such as ferroptosis, release of neutrophil extracellular traps (NETs), and nitrosative stress, which offer promising avenues for the management of CI-AKI, are identified. Secondly, a comprehensive strategy for the early prevention of CI-AKI is introduced. Investigating the risk factors associated with CI-AKI is essential for the timely identification of high-risk groups. Additionally, exploring early sensitive biomarkers is crucial for early diagnosis. A synergistic approach that combines these sensitive biomarkers, CI-AKI risk factors, and disease risk prediction models enhances both the accuracy and efficiency of early diagnostic processes. Finally, we explore recent pharmacological and non-pharmacological interventions for the management of Cl-AKI. Beyond the traditional focus on the antioxidant N-acetylcysteine (NAC), we look at active compounds from traditional Chinese medicine, including tetramethylpyrazine (TMP), salvianolic acid B (Sal B), as well as emerging preventive medications like N-acetylcysteine amide (NACA), alprostadil, and others, which all showed potential benefits in animal and clinical studies for CI-AKI prevention. Furthermore, innovative strategies such as calorie restriction (CR), enhanced external counterpulsation (EECP), and mesenchymal stem cell therapy are highlighted as providing fresh insights into Cl-AKI prevention and management.

Contrast-induced Nephropathy in CT: Incidence, Risk Factors and Strategies for Prevention.

Risk factors and recent advances in the prevention of contrast - induced nephropathy

Contrast-Induced Nephropathy: A Review of Mechanisms and Risks

The Controversy of Contrast-Induced Nephropathy With Intravenous Contrast: What Is the Risk?

Advances in prevention of contrast-induced nephropathy after coronary angiography or intervention

Contrast-associated Acute Kidney Injury: an Update of Risk Factors, Risk Factor Scores, and Preventive Measures

Unveiling the Mysteries of Contrast-Induced Acute Kidney Injury: New Horizons in Pathogenesis and Prevention

[Early prevention progress of contrast induced nephropathy]

The Research Progress of Contrast Media Induced Nephropathy

The pathogenesis and preventive measures of contrast-induced nephropathy

Contrast-induced nephropathy and oxidative stress: mechanistic insights for better interventional approaches

Key Considerations regarding the Renal Risks of Iodinated Contrast Media: The Nephrologist's Role

Current evidence on prevention and management of contrast-induced nephropathy

Contrast-induced nephropathy in interventional cardiology

Epidemiology of contrast-induced nephropathy after computerized tomography

The Molecular Mechanism of Contrast-Induced Nephropathy (CIN) and Its Link to in Vitro Studies on Iodinated Contrast Media (CM)

Acute Kidney Injury in Patients with Nephrotic Syndrome Undergoing Contrast-Enhanced CT for Suspected Venous Thromboembolism: a Propensity Score-Matched Retrospective Cohort Study

Prevention of Contrast-Induced Acute Kidney Injury: an Update

Prevention of contrast-associated acute kidney injury in an era of increasingly complex interventional procedures

Contrast Induced Nephropathy: an Ignored Important Complication in Interventional Radiology

Ultra-low contrast coronary angiography and zero-contrast percutaneous coronary intervention for prevention of contrast-induced nephropathy: step-by-step approach and review